InicioPodcastsThe Long Run with Luke TimmermanEp204: Troy Wilson on Precision Cancer Drugs and CombosThe Long Run with Luke TimmermanEp204: Troy Wilson on Precision Cancer Drugs and Combos30 de junio de 2026 · 1 h 7 minReproducir episodioCompartir desde este puntoNotas del episodioTroy Wilson, CEO of San Diego-based Kura Oncology, on his career in biotech and developing targeted cancer drugs.Todos los episodios de The Long Run with Luke Timmerman